Catalyst Wire Dossier Catalyst Wire Dossier

Irinotecan

Irinotecan
Drug timelines are a Plus or Pro feature.

508 regulatory and trial events tracked for Irinotecan, covering 2006-07-19 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]

See pricing